Drugs / AGN208397
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT01027650 | Mar 2010 → Apr 2012 | macular retinal edema, retinal vein occlusion | Allergan | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | AGN208397 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01027650 ↗ |
| Route | Intravitreal | “AGN208397 intravitreal injection on Day 1.” NCT01027650 ↗ |